BACK TO BACK LATEST NEWS

BACK TO BACK LATEST NEWS, Official Website about ,all over the world latest news, Entertainment,Sports,Health,Fashion Hollywood,Bollywood ,Business,Latest Stories,Political news,Stock market news,and Hot news and more other topics

Tuesday, November 6, 2018

LATEST HEALTH NEWS

Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used to treat certain cancer and rheumatoid arthritis.


from Reuters: Health News https://ift.tt/2AIQ9bz

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Followers

Contact Form

Name

Email *

Message *

Popular Posts

  • LATEST TECHNOLOGY NEWS
    Work tools startup Notion , which recently reached a reported $800 million valuation , isn’t on the verge of a big SoftBank round. In fact, ...
  • LATEST BUSINESS NEWS
    Mukesh Ambani also mentioned that Jio has already created over 40,000 direct and indirect jobs in Uttar Pradesh from Economy & Policy ...
  • LATEST BUSINESS NEWS
    It’s hard to imagine how McDonalds or Starbuck ever had humble beginnings. But every business has to start from somewhere. As a well-known s...
  • LATEST TECHNOLOGY NEWS
    Did you know that 80 percent of users churn within three months of downloading an app? That’s because most apps are marketed to the masses...
  • LATEST TOP STORIES
    from Yahoo News - Latest News & Headlines https://ift.tt/3m09sUR

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner

Copyright © BACK TO BACK LATEST NEWS | Powered by Blogger